Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Matthew J. Brady to Insulin Receptor Substrate Proteins

This is a "connection" page, showing publications Matthew J. Brady has written about Insulin Receptor Substrate Proteins.

 
Connection Strength
 
 
 
0.569
 
  1. Sargis RM, Neel BA, Brock CO, Lin Y, Hickey AT, Carlton DA, Brady MJ. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60.
    View in: PubMed
    Score: 0.468
  2. Brady MJ. IRS2 takes center stage in the development of type 2 diabetes. J Clin Invest. 2004 Oct; 114(7):886-8.
    View in: PubMed
    Score: 0.070
  3. Neel BA, Brady MJ, Sargis RM. The endocrine disrupting chemical tolylfluanid alters adipocyte metabolism via glucocorticoid receptor activation. Mol Endocrinol. 2013 Mar; 27(3):394-406.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.